2.25TWD
375.17 MTWD
2.96 BTWD
152.30 M
About SINPHAR PHARMACEUTICAL CO LTD
Sector
CEO
Yu-Liang Pei
Headquarters
I-lan
Website
Founded
1977
ISIN
TW0001734002
FIGI
BBG000F89247
Sinphar Pharmaceutical Co. Ltd. engages in the production, processing, and trading of medicines, Chinese medicines, medical cosmetic products, and nutrients. It operates through the following segments: Pharmaceutical, Healthy Food, and Others. The company was founded on July 2, 1977 and is headquartered in I-lan, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1734 is 36.40 TWD — it has decreased by 0.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange SINPHAR PHARMACEUTICAL CO LTD stocks are traded under the ticker 1734.
SINPHAR PHARMACEUTICAL CO LTD is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track SINPHAR PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 1734 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINPHAR PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINPHAR PHARMACEUTICAL CO LTD EBITDA is 529.58 M TWD, and current EBITDA margin is 17.87%. See more stats in SINPHAR PHARMACEUTICAL CO LTD financial statements.